The study is open to members of the public who are at least 18 years old and use a smartwatch or activity tracker, such as an Apple Watch or Fitbit. Participants have the option to share their EHR data with the Scripps researchers as well as their heart rate, activity levels, sleep data and logged respiratory symptoms and diagnostic results.
“In light of the ongoing flu season and the global pandemic of COVID-19, we see enormous opportunity to enhance disease tracking for improved population health,” said Jennifer Radin, PhD, an epidemiologist at the Scripps Research Translational Institute and leader of the study, according to the news release. “One way to do this is to leverage and analyze the rich health data that’s already being collected by the millions of Americans who regularly use wearable devices.”
By examining individual users’ health data changes on a daily basis, the research team hopes to identify when a participant has a viral infection much earlier in its course to start treatment and isolation earlier.
Individuals who choose to participate in the study must consent to sharing their data by downloading the MyDataHelps mobile app. Scripps Research partnered with health tech company CareEvolution, which supports the secure exchange of clinical health data, to develop the app-based study.
More articles on health IT:
UC San Diego Health builds EHR tools to manage COVID-19
New York seeking IT talent for COVID-19 tech ‘SWAT team’
AHA pleads for HIPAA waiver clarification, extension
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
